日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex

EED 靶向 PROTAC 降解 PRC2 复合物中的 EED、EZH2 和 SUZ12

Jessie Hao-Ru Hsu, Timothy Rasmusson, James Robinson, Fiona Pachl, Jon Read, Sameer Kawatkar, Daniel H O' Donovan, Sharan Bagal, Erin Code, Philip Rawlins, Argyrides Argyrou, Ronald Tomlinson, Ning Gao, Xiahui Zhu, Elisabetta Chiarparin, Kelly Jacques, Minhui Shen, Haley Woods, Emma Bednarski, David

ERG6 and ERG2 Are Major Targets Conferring Reduced Susceptibility to Amphotericin B in Clinical Candida glabrata Isolates in Kuwait

ERG6 和 ERG2 是科威特临床分离的光滑念珠菌对两性霉素 B 敏感性降低的主要靶点

Suhail Ahmad, Leena Joseph, Josie E Parker, Mohammad Asadzadeh, Steven L Kelly, Jacques F Meis, Ziauddin Khan

BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors

BRD4 扩增促进高级别浆液性卵巢癌中的致癌基因表达程序并赋予对 BET 抑制剂的敏感性

Garrett W Rhyasen, Yi Yao, Jingwen Zhang, Austin Dulak, Lillian Castriotta, Kelly Jacques, Wei Zhao, Farzin Gharahdaghi, Maureen M Hattersley, Paul D Lyne, Edwin Clark, Michael Zinda, Stephen E Fawell, Gordon B Mills, Huawei Chen

Tumors with AKT1E17K Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors

AKT1E17K 突变肿瘤是 AKT 抑制剂单药治疗或联合治疗的合理靶点

Barry R Davies, Nin Guan, Armelle Logie, Claire Crafter, Lyndsey Hanson, Vivien Jacobs, Neil James, Philippa Dudley, Kelly Jacques, Brendon Ladd, Celina M D'Cruz, Michael Zinda, Justin Lindemann, Makoto Kodaira, Kenji Tamura, Emma L Jenkins